Interesting comment from PVD's quarterly this morning:
"During the quarter the Company purchased 89,104,742 shares in Factor Therapeutics Limited (FTT). The Pura Vida boardidentified the possibility of the pending R&D cash return to FTT and believed there was value that could be created by taking an equity position in the company."
So, for no other reason than an opportunistic, speculative punt eh?
Hmm....
Note: My bold and underline.
- Forums
- ASX - By Stock
- DLM
- Ann: Appendix 4C - March 2019 Quarter
Ann: Appendix 4C - March 2019 Quarter, page-9
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable